Stories about physicians and other healthcare professionals involved in lawsuits—as either a plaintiff or a defendant—or accused of breaking the law. Various legal updates or unusual stories in the news may land here.
A malpractice lawsuit filed by a gender detransitioner ended Jan. 30 with a victory for the aggrieved former patient. The decision may set a generalizable precedent since this was the first such suit to reach a courtroom—and since 30 or so others are en route.
A surgeon and a medical device representative accuse Portneuf Medical Center of failing to address an ongoing problem with contaminated surgical tools that left patients with serious infections.
Heated tension between state and federal AI regulators is coming, predict two attorneys subspecialized in AI startup success, data privacy and cybersecurity.
The rad was accused of writing a “confusing” report that allegedly had long-lasting implications for the plaintiff's child, who was born with severe birth defects.
The U.S. Department of Justice said policies at CVS Health forbade pharmacists from discussing patients and providers who may be prescribing opiates in violation of the Controlled Substance Act.
The cardiologist suffered multiple fractures, had to have a blood clot removed from his skull and now has permanent hearing loss in one ear. He was also left with “severe and crippling depression" following the attack.
A lawsuit filed by the family of Philip Tong, 45, claims he was experiencing severe emergency symptoms that staff at Amazon One Medical should have recognized as life-threatening.
More than 100 plaintiffs have now sued the Marlborough, Massachusetts-based mammography-maker, claiming they suffered injuries and emotional distress stemming from implantation of the BioZorb radiographic marker.
State Attorney General Mike Hilgers said he decided to sue because of Change Healthcare's evident carelessness as well as its slowness to inform potential victims.
The Patients Before Monopolies Act, introduced in both the House and Senate, gives parent companies of PBMs three years to divest from pharmacies or face penalties.